Well, indeed, and it wasn't good news for AGEN either. Sort of reminds me recently of a fashion magazine which profiled (interviewed) Sheryl Crow about her engagement last fall to Lance Armstrong, only to find out upon the release of that publication that the latest news was they had now broken up!
Oooops!
I believe CEGE's CEO Shervin put out a realistic forecast. My question is who will be the first "success"? DNDN? I believe this field is very exciting/revolutionary from a scientific point of view, as an innovative way to treat cancer, as well as financial investment. The growing pains may soon (12-18 months) result in investment gains.
For cancer vaccines, the cycle of hyperbole, disappointment, and success now appears closer to the end than to the beginning. Okarma believes his stem cell plan could be less than three years away, and several other vaccines are poised to test the waters before then. "There will be more failure, but I am absolutely confident there will be success," Sherwin says. "It only takes one success to wipe away years of skepticism."
News 
Market Data 
Discover 
